All oveporexton articles
-
NewsTakeda’s Orzeyful approved in US as first-in-class orexin treatment for narcolepsy Type 1
FDA’s authorisation addresses the condition’s full symptom burden instead of just symptomatic relief.
-
NewsTakeda investigational drug shows efficacy in narcolepsy
If approved, the oral medicine could provide a first-in-class treatment option for eligible individuals with the chronic 24-hour disease.